2007
DOI: 10.1053/j.gastro.2006.12.035
|View full text |Cite
|
Sign up to set email alerts
|

Increased Gene and Protein Expression of the Novel eNOS Regulatory Protein NOSTRIN and a Variant in Alcoholic Hepatitis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
43
0
1

Year Published

2007
2007
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 48 publications
(52 citation statements)
references
References 31 publications
8
43
0
1
Order By: Relevance
“…4A). The development of ammoniainduced ROS production was further quantitatively measured as described previously, [34] and confirmed that primary hHSCs treated with ammonia produced significant ROS (Fig. 4B).…”
Section: Hyperammonemia Induces Ros Production In Hhscsupporting
confidence: 81%
See 1 more Smart Citation
“…4A). The development of ammoniainduced ROS production was further quantitatively measured as described previously, [34] and confirmed that primary hHSCs treated with ammonia produced significant ROS (Fig. 4B).…”
Section: Hyperammonemia Induces Ros Production In Hhscsupporting
confidence: 81%
“…7C). eNOS protein expression was significantly increased in BDL rats compared to sham animals (as we previously described [34]) and this remained statistically unchanged after OP therapy (Fig. 7C).…”
Section: In Vivo Study Ii: Treatment With Op Improves Portal Pressuresupporting
confidence: 78%
“…NO is one of the essential regulators of intrahepatic vascular tone and decreased production of NO results in portal hypertension (Iwakiri et al, 2008;Sanyal et al, 2008). NOS inhibitors such as caveolin-1 (Shah et al, 1999), ADMA (Mookerjee et al, 2007b), and NOSTRIN (Mookerjee et al, 2007c) play roles in the occurrence of portal hypertension. Severity of portal hypertension is correlated with levels of ADMA (Mookerjee et al, 2007b).…”
Section: Discussionmentioning
confidence: 99%
“…32,38 Additional antibodies were monoclonal eNOS and monoclonal peNOS Ser 1179 antibody (BD Bioscience, Heidelberg, Germany), polyclonal rabbit anti-M3R antibody (Santa Cruz Biotechnology, Heidelberg, Germany), polyclonal goat anti-platelet endothelial cell adhesion molecule-1 antibody (BD Bioscience, Heidelberg, Germany), polyclonal anti-caveolin-1 antibody (Santa Cruz Biotechnology, Heidelberg, Germany), monoclonal mouse anti-GAPDH antibody (Abcam, Cambridge, United Kingdom), monoclonal anti-extracellular signal-regulated protein kinases 1 and 2 (ERK1/2; Cell Signaling Technology, Leiden, The Netherlands), monoclonal mouse anti-maltose-binding protein (NEB, Ipswich, MA), and polyclonal rabbit anti-green fluorescent protein antibody (Clontech, Saint-Germain-en-Laye, France).…”
Section: Antibodiesmentioning
confidence: 99%